In 2016, we worked with third party partner, The Carbon Trust, on a lifecycle assessment to recertify the product carbon footprints of three different bags of Flexbumin 25% [Albumin (Human)] sold in the U.S., Europe, Latin America, and Asia. From plasma collection, to manufacturing, distribution, and end-of-life, the assessment looked at the whole product lifecycle to understand where the biggest carbon impacts arose.
